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Although neuronal pathology and synaptic loss are
salient features of Alzheimer’s disease (AD), the underlying mechanisms involved are unknown. Using doubleimmunolabeled preparations, we found that both the
density and the total lengths of axons are decreased
within the Ab-containing area of senile plaques (SP) in
comparison with the adjacent neuropil. These observations suggest that axotomy is occurring in the vicinity
of the SP which could account for the synaptic loss.
Since Ab in solution has been shown to be neurotoxic
in vitro, we tested whether intact SP cores isolated
from AD brain were equally detrimental when presented to retinal ganglion neurons. Surprisingly, SPs
did not appear to be toxic or even repulsive to neurons
since they adhered well and elaborated axons which
wrapped tightly around the SP core. In the presence of
cortical astrocytes, however, neurons appeared to avoid
SP cores. We found that astrocytes accumulate and
deposit chondroitin sulfate proteoglycans (CSPGs)
around SP cores in vitro in a pattern similar to that
observed around SPs in Alzheimer’s disease brain.
Neuronal avoidance of astrocyte-conditioned SP cores
could be due to the axon outgrowth inhibitory nature
of CSPGs. These results suggest that astrocytic reaction to SPs, including increased CSPGs, may facilitate
the decreased axon density and synaptic loss in AD
brain. Moreover, the similarities between swollen axon
endings following axotomy in trauma and the dystrophic neurites of the SP suggest that dystrophic neurites in AD may be exhibiting regenerative failure
rather than aberrant sprouting. r 1996 Academic Press, Inc.

INTRODUCTION

Senile plaques (SPs) of Alzheimer’s disease are cellularly and molecularly complex structures. Reactive
astrocytes (5, 21, 28, 30), activated microglia (14, 17,
24), and dystrophic neurites are present in SPs. In
addition to Ab, over 40 protein components have been
identified which accumulate in the SP including proteases (30), protease inhibitors (1, 11, 18), growth factors
(12, 39), and extracellular matrix proteins (16) including proteoglycans (9, 32–35). How all of the various SP

components interact in the pathogenesis of Alzheimer’s
disease (AD) is far from clear.
Alzheimer’s disease pathology includes loss of specific neuronal populations, synapse loss, senile plaques,
and neurofibrillary tangles. While both SPs and neurofibrillary tangles are inexorably linked with Alzheimer’s disease, synaptic loss shows the strongest linkage to severity of dementia (23, 38). Although global
loss of synapses occurs in the brains of individuals with
Alzheimer’s disease, synapse loss is accentuated within
core containing senile plaques (22). Dystrophic neurites, found around SPs, are swollen neuronal processes which contain the same abnormal cytoskeletal
elements and accumulated proteins found in neurofibrillary tangles (8, 13, 19, 21, 27). The mechanism(s)
involved in synaptic loss and induction of neuritic
dystrophy has not been defined, although Ab has been
suggested by many to underlie the neuronal pathology.
Numerous studies have suggested that Ab is neurotoxic in vitro; however, most studies of in vivo brain
injections of Ab have not shown consistent neurotoxicity (31). When synthetic Ab is presented as a substrate,
neurons adhere and elaborate axons normally (5, 20).
Further, when neurons were grown on cryostat sections
from Alzheimer’s disease brain, they readily adhered
and survived even on SPs (6). Interestingly, these
neurons avoided the senile plaque periphery, an area
which is rich in chondroitin sulfate proteoglycans (9).
Nonetheless, the demonstration of Ab toxicity in solution (i.e., neuronal death) is not equivalent to Ab
induction of neuritic dystrophy (i.e., a living neuron
with swollen, torturous neurites), which to our knowledge has not yet been shown.
One hypothesis that has been put forth to explain
neuritic dystrophy is that it is caused by aberrant
sprouting (10). In such a scenario, an increased amount
of growth factors and growth-promoting extracellular
matrix molecules in the SP vicinity is suggested to
provide a strong trophic signal to neurons, causing
them to sprout abnormally. If this were true, one might
expect to find an increase in the density or total length
of axons within the SP area. In the present study, we
have tested this hypothesis using double immunolabeled partial reconstructions to determine the density
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and lengths of axons within the Ab-containing area of
the SP. In this study, we present the hypothesis that
synapse loss and possibly neuritic dystrophy in the SP
are the result of a process of regenerative failure akin to
that which occurs following axotomy in the adult CNS
due to trauma.
MATERIALS AND METHODS

Axon Density/Length Analysis
Sections from frontal cortex or hippocampus from
three confirmed cases of Alzheimer disease were studied. Tissue was fixed in methacarn (methanol 6: chloroform 3: acetic acid 1) and embedded in paraffin prior to
sectioning. 38,38-Diaminobenzidine was used as the
cosubstrate with the peroxidase anti-peroxidase method
for immunostaining (37). SPs were verified by Congo
red or RGP-9, an antisera to Ab (gift of George Perry,
Case Western Reserve University). Normal neurites
were identified with SMI-31, a monoclonal antibody to
phosphorylated neurofilament. This antibody also stains
dystrophic neurites which can be identified by their
size and shape.
In order to determine axon density and total length
within SPs, double-immunolabeled preparations were
stained with SMI-31 and RGP-9. SMI-31 was visualized using DAB while RGP-9 was visualized using
alkaline phosphatase as previously described (9). Up to
four adjacent 10-µm sections were immunostained in
order to verify that a particular SP was a corecontaining plaque. Following verification, the area occupied by Ab was determined using the Quantimet image
analysis system with the 40X objective. The number,
lengths, and widths of axons within the total area
occupied by Ab in core-containing plaques were also
determined using the Quantimet system. In some
cases, paired measures of non-Ab-containing control
areas were also obtained. In this case, the stage was
moved to a random field within 150 µm of the SP and
within the same brain layer. The number, lengths, and
widths of axons in the normal neuropil in an area
equivalent to the senile plaque were determined. Total
axon length was determined by summing the lengths of
all axons within the specified areas.
Isolation of Senile Plaque Cores
SP cores were isolated as previously described (29).
Briefly, portions of frontal and temporal lobe from
individuals with confirmed, severe Alzheimer’s disease,
were obtained at autopsy and frozen. Gray matter was
homogenized and brought to 97°C for 10 min in 2%
SDS, 1 mM Tris (pH 7.6), sieved through 110-µm nylon
mesh, and centrifuged at 300g for 30 min to pellet the
core-containing fraction. The samples were then washed

in 0.1% SDS, 150 mM NaCl, 0.02% NaN3 and centrifuged again at 300g for 10 min. The samples were
sieved through a 35-µm nylon mesh and then applied to
a noncontinuous sucrose gradient (1.2, 1.4, 1.6, and 1.8
M sucrose) and centrifuged again at 72,000g for 60 min.
Most of the SP cores were collected from the 1.4–1.6 M
interface. SP cores were stored at 4°C until use.
Neuronal Cultures
Chick retinal ganglion neurons were obtained by
carefully dissecting the retina from stage 29 or 30 (,E6
or E7) chick embryos and briefly dissociating the tissue
in trypsin. The neurons were plated on poly-L-lysinecoated coverslips and grown in DMEM-F12 medium
(Gibco) with insulin, transferin, sodium selenate supplement (Sigma), and only 1% fetal calf serum. Neurons
were grown on coverslips which previously had up to
500 isolated SP cores dried to the poly-L-lysine-coated
substrate. In some cases, the SP cores were coated with
laminin to promote robust neurite outgrowth.
Astrocyte Cultures/Neuronal Co-cultures
Astrocytes were obtained from the cortex of P0
Sprague–Dawley rat pups. Mixed glial cultures were
grown on poly-L-lysine-coated flasks with DMEM-F12
(Gibco) and 10% fetal calf serum. After 24 h, microglia
and other cell types were removed through shaking.
The remaining astrocytes were used after 2 weeks in
culture. About 5 3 104 cells per well were grown with
SP cores for 1–2 weeks prior to the addition of neurons.
Astrocyte-conditioned SP cores were also processed for
immunocytochemistry.
Immunocytochemistry
Immunocytochemistry followed the method of Sternberger (37). Coverslips were fixed in 2% paraformaldehyde in 1 M PBS, pH 7.2, for 1 h and rinsed with 1 M
PBS. Endogenous peroxidase activity was blocked with
3% hydrogen peroxide for 30 min followed by a 30-min
incubation in saturated Congo red solution (70% ethanol, saturated with NaCl) to aid in the identification of
SP cores. The coverslips were further blocked with 10%
normal goat serum for 30 min prior to the addition of
primary antibodies. SP core material was verified with
the monoclonal 4G8 or polyclonal antisera raised to Ab.
Primary antibodies GFAP (astrocyte marker), CS-56
(chondroitin sulfate glycosaminoglycan) (7), and TUJ1
(neuronal marker) were incubated on the coverslips
overnight at 4°C. Goat vs mouse or goat vs rabbit
secondaries were applied with fluorescent tagged or
peroxidase anti-peroxidase as tertiary antibodies. Diaminobenzidine was used as chromagen with peroxidase-conjugated antibodies.
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RESULTS

Axonal Loss in Senile Plaques
Sections through the hippocampus from individuals
with Alzheimer’s disease which have been immunolabeled for neurofilament protein contain large numbers
of ‘‘axon holes’’ where the SP core is located. Anti-
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neurofilament-stained preparations show axon clearings in the area of the SP (Figs. 1A and 1C) which is
demonstrated in the adjacent sections (Figs. 1B and
1D). In order to quantitate the extent of axonal loss,
axon density and total axon length were determined for
the entire Ab-containing area of the SP. These results
are summarized in Table 1, which confirms that the

FIG. 1. Antibody to neurofilament protein (SMI-31) reveals axonal staining as well as ‘‘axonal holes’’ (arrows) in the area of a senile plaque
(A,C). The adjacent sections double-immunolabeled for Ab (RGP-9, purple) demonstrate that the axonal hole is within the Ab-containing area
of the senile plaque (B,D). Dystrophic neurites are generally found in a radial pattern around the senile plaque (E). Scale bars, 20 µm.
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TABLE 1
Neurite Analysis—Comparison of the Density and Total
Length of Axons within the Ab-Containing Area of a Core
Containing Senile Plaque and Areas without Ab

Total area
No. neurites/area
Average neurite length
Average neurite width
Neurite length per area

Normal neuropil

Senile plaque

3033 µm2
13.8 N/1000
µm2 6 2.76 SE
9.14 µm 6 0.89 SE
1.04 µm 6 0.11 SE
126 mm N/mm2

9113 µm2
4.4 N/1000
µm2 6 1.4 SE
7.23 µm 6 0.69 SE
1.48 µm 6 0.12 SE
32.6 mm N/mm2

density of axons within SP is significantly decreased in
comparison with the adjacent neuropil. Moreover, the
total length of all axon segments within SPs was also
substantially lower than the adjacent area lacking Ab.
These results are consistent with the hypothesis that
Ab or other components present in the SP lead to
physiological or de facto axotomy or axon retraction.
Neurons Elaborate Axons on Senile Plaque Cores
in Vitro
Since numerous in vitro studies have suggested that
aggregated Ab in solution is neurotoxic, this protein
seemed a likely candidate responsible for axonal loss in
vivo. In order to determine whether Ab in the context of
an intact SP might be responsible for axotomy, we
developed a novel model in which SPs isolated from AD
brain are presented to neurons. By drying the SPs to
the coverslips prior to addition of neurons, the Ab is
presented as a 3-dimensional, aggregated, chronic, and
focal source much as it may be in vivo. This presentation of Ab allowed individual neurons to ‘‘choose’’
whether or not to interact with the SP. Initially, SP
cores and the poly-L-lysine substrate were coated with
laminin to facilitate neuronal adhesion as well as to
promote neurite outgrowth. Neurons grew in close
proximity to SP cores and wrapped axons around them.
Since the laminin coating may have hindered detrimental effects of Ab, neurons were also grown on SP cores
without laminin. In this case, neurons still adhered to
SP cores and elaborated axons toward and tightly
hugging the core (Fig. 2E).

Astrocytes Accumulate CSPGs Which May Inhibit
Axon Outgrowth
Astrocytes show increased GFAP immunoreactivity
in association with SPs in AD brain (Fig. 2A). This
increase is paralleled in vitro when rat cortical astrocytes are grown on isolated SP cores (Fig. 2C). We have
previously shown that astrocytes deposit increased
amounts of CSPGs in the extracellular matrix when
grown on a synthetic Ab peptide substrate (5). Therefore, we asked whether astrocytes might also accumulate or deposit CPSGs in response to isolated SP cores.
Indeed, we found that astrocytes in contact with SP
cores show increased CSPG immunoreactivity around
the core periphery (Fig. 2D). CSPG accumulated in a
ring-like pattern just as observed in AD brain (Fig. 2B).
Neurons Avoid Astrocyte-Conditioned Senile
Plaque Cores
Since certain CSPGs have been found to inhibit axon
outgrowth in vitro (5, 25, 36), we asked whether the
response of astrocytes to SP cores might alter the usual
neuronal response of growing in intimate contact with
the SP cores. Astrocytes were allowed to react to SP
cores for 1–2 weeks prior to addition of neurons.
Indeed, following astrocyte conditioning of bound SP
cores, axons appeared to grow further from the SP core
perimeter and in some cases appeared to avoid the
astrocyte-conditioned SP cores altogether (Fig. 2F).
These results are consistent with the possibility that
astrocytes deposit an axon repulsive extracellular matrix in response to SPs.
DISCUSSION

In this study we have demonstrated that both the
density of axons as well as the total lengths of axons are
substantially decreased within the Ab-containing area
of the SP. However, these results alone, while consistent with axotomy within the SP, do not help to clarify
which factors are responsible for axonal loss or neuritic
dystrophy. Since Ab has been suggested to be neurotoxic, we examined the effects of SP cores, isolated from
the cortex of individuals with Alzheimer’s disease, on
neurons in vitro. Surprisingly, neurons adhered to SP
cores and elaborated axons which wrapped tightly
around the core surface, suggesting that factors other

FIG. 2. In AD brain, astrocytes are hypertrophied and show increased GFAP immunoreactivity (brown) in association with a senile plaque
(c) core (A). CSPG immunoreactivity reveals an increase in the vicinity of the senile plaque periphery (B) which partially overlaps GFAP. Rat
cortical astrocytes growing on SP cores in vitro show increased GFAP immunoreactivity (C) and CSPG immunoreactivity (D) (CS-56, brown)
immediately adjacent to the senile plaque (c) core. The pattern of GFAP and CSPG immunoreactivity in vitro is similar to that found around
senile plaques in AD brain (compare A and B with C and D). Retinal ganglion neurons grew in close association with senile plaque (c) cores
isolated from AD brain (E, arrow). When neurons were grown on astrocytes which had reacted to SP cores for 2 weeks, the neurons avoided the
area of the SP and axons appeared to curve away (F, arrows). Scale bars, 20 µm.
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than or in addition to Ab may be involved in the axonal
loss in vivo. However, when neurons were grown on
astrocytes responding to SP cores, axons now avoided
such conditioned SP cores altogether. These results are
consistent with the possibility that enhanced deposition of axon inhibitory CSPGs, or other sulfated proteoglycans, by reactive astrocytes could be an additional
factor promoting neuronal pathology in the SP.
Previously, Benes et al. (2) compared the axon density within and immediately outside the core of SPs.
They found that the axon density was decreased within
the core and up to two plaque core distances away and
argued that if the mere presence of Ab pushed axons
out (or induced excessive sprouting), then there would
be an increased density immediately outside the core.
Since this does not occur, they suggested that there was
axonal loss within and adjacent to the SP core, which
would be consistent with axotomy. We have confirmed
and extended these findings to include a decrease in the
total length of axons within the SP.
Additional evidence suggests that the periphery of
the SP, rather than the core itself, may have the
greatest impact on neurons. Carpenter et al. (6) grew
neurons on cryostat sections from AD brain. There was
no difference in the density of neurons which adhered
to SP cores and those which adhered to areas lacking
SPs. However, the number which adhered to the periphery of the SP was significantly reduced. Further, neurons growing in the peri-plaque region showed inhibited axon outgrowth and the axons appeared to avoid
this area. These results, along with the finding of
decreased axon density in SPs in vivo, strongly suggest
that a factor(s) within the SP periphery exerts an
inhibitory effect on axon outgrowth.
A likely factor involved could be proteoglycans. Previously, we localized CSPG accumulation to the periphery
of SPs—the same area shown to inhibit axon outgrowth
in the cryostat model (6). In addition, we (9) found that
astrocytes respond to a synthetic Ab substrate with the
deposition of axon repulsive amounts or types of CSPGs
(5). The results of the present study provide further
evidence that the accumulation of CSPGs by astrocytes
in response to SP may, indeed, have detrimental (i.e.,
barrier) effects on neurons.
Is it possible that CSPGs and/or reactive astrocytes
in addition to forming a barrier to regeneration also
promote neuronal dystrophy in the first place? The first
evidence in support of this has come from a recent
paper by Holtmatt and colleagues (15) who examined
primary sensory olfactory axons in adult animals genetically engineered to overproduce GAP-43. When these
axons are compelled to regenerate into areas around
the glomerulus that are rich in reactive astrocytes and
CSPG, they develop enlarged, paddle-shaped, dystrophic endings and varicosities. Although the authors did
not mention Alzheimer’s disease in this paper, these

unusual axon endings bear striking similarities to the
dystrophic neurites of the SP as well as the sterile
endings described following trauma (4). Such truly
dystrophic neurites have yet to be generated in vitro in
response to Ab or proteoglycans, perhaps because only
embryonic neurons have been used or because of an
inappropriate 3-dimensional presentation. However,
the spherical nature of the peri-glomerular region and
its striking similarity to the penumbra of the SP may
enable us to begin to understand how neuronal dystrophy, reactive astrocytes, and proteoglycans are interrelated.
The aberrant sprout hypothesis of neuritic dystrophy
(10) has received much support because of the many
growth factors and growth-promoting molecules which
have been found in SPs including bFGF (12), laminin,
and collagen (26). Although it has been suggested that
excessive or abnormal sprouting of neurites due to
increased trophism may cause neuritic dystrophy, the
relation of trophic molecules to regeneration has not
been overlooked (22). Indeed, GAP43 and other growthpromoting/associated molecules which are present in
SPs are also characteristic of wound- or regenerationrelated events.
This suggests a different view of the abnormal neurites and extracellular matrix proteins in SPs. Our
morphometric analysis of AD tissue raises the possibility that instead of a totally growth-promoting, trophic
environment for excessive neurite outgrowth, the swollen nature of the dystrophic neurites suggests that the
environment of the SP periphery may prevent the
restoration of synapses by inhibiting neuritic sprout
infiltration into the area. Such an idea has support
since the bulbous, dystrophic neurites found in SPs of
AD brain differ from degenerating neurites found in
other neurological conditions (3). These other neurodegenerative diseases are not characterized by the large,
focal extracellular deposits of wound-related molecules
which occur in Alzheimer’s disease. Thus, we suggest
that the dystrophic neurites of Alzheimer’s disease are
remarkably similar to the abortive sprouts with sterile
clubs classically described by Cajal which occur in
regenerative failure (4). Therefore, we propose that the
dystrophic neurites in AD are undergoing abortive
regeneration rather than aberrant sprouting.
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